117 related articles for article (PubMed ID: 24901031)
1. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Lenz E; Sprunk A; Kleinebudde P; Page S
Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution of sildenafil citrate as dry foam tablets.
Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
[TBL] [Abstract][Full Text] [Related]
3. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
Bolhuis GK; Rexwinkel EG; Zuurman K
Drug Dev Ind Pharm; 2009 Jun; 35(6):671-7. PubMed ID: 19274511
[TBL] [Abstract][Full Text] [Related]
4. New orodispersible mini-tablets for paediatric use - A comparison of isomalt with a mannitol based co-processed excipient.
Lura A; Luhn O; Suarez Gonzales J; Breitkreutz J
Int J Pharm; 2019 Dec; 572():118804. PubMed ID: 31678381
[TBL] [Abstract][Full Text] [Related]
5. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
[TBL] [Abstract][Full Text] [Related]
6. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
Hugo M; Kunath K; Dressman J
Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
[TBL] [Abstract][Full Text] [Related]
7. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
9. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
[TBL] [Abstract][Full Text] [Related]
10. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
Sprunk A; Page S; Kleinebudde P
Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
[TBL] [Abstract][Full Text] [Related]
11. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets.
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Jan; 554():54-60. PubMed ID: 30278257
[TBL] [Abstract][Full Text] [Related]
13. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
14. A One-Step Twin-Screw Melt Granulation with Gelucire 48/16 and Surface Adsorbent to Improve the Solubility of Poorly Soluble Drugs: Effect of Formulation Variables on Dissolution and Stability.
Sarabu S; Kallakunta VR; Butreddy A; Janga KY; Ajjarapu S; Bandari S; Zhang F; Murthy SN; Repka MA
AAPS PharmSciTech; 2021 Feb; 22(3):79. PubMed ID: 33606113
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
16. Dissolution rate enhancement of gliclazide by ordered mixing.
Saharan VA; Choudhury PK
Acta Pharm; 2011 Sep; 61(3):323-34. PubMed ID: 21945911
[TBL] [Abstract][Full Text] [Related]
17. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
18. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
Wenzel T; Stillhart C; Kleinebudde P; Szepes A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
[TBL] [Abstract][Full Text] [Related]
19. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole.
Madgulkar A; Bandivadekar M; Shid T; Rao S
Drug Dev Ind Pharm; 2016 Jan; 42(1):28-38. PubMed ID: 25874729
[TBL] [Abstract][Full Text] [Related]
20. Formulation of fenofibrate liquisolid tablets using central composite design.
Patel T; Patel LD; Suhagia BN; Soni T; Patel T
Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]